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Summary 
We recently demonstrated that stimulation of gp 130 by a combination of soluble interleukin  6 
receptor (slL-6R) and IL-6 but not IL-6 alone significantly stimulates the ex vivo expansion of 
primitive hematopoietic progenitors and the generation of erythroid cells from human CD34 + 
cells in the presence of stem cell factor (SCF).  Here, we show that gp130 is found low posi- 
tively on  most CD34 +  cells,  whereas  IL-6R is expressed  on  only 30-50%  of these  cells.  Al- 
though most of the colonies generated from FACS|  CD34+IL-6R + cells were granulo- 
cyte/macrophage  (GM)  colonies,  CD34+IL-6R -  cells gave rise  to various  types of colonies, 
including  erythroid bursts,  GM,  megakaryocytes, and  mixed colonies  in methylcellulose  cul- 
ture  with  a  combination  of IL-6, slL-6R,  and  SCF.  Similar results  were  obtained  in  culture 
supplemented  with a combination  of IL-3, IL-6, SCF,  granulocyte  colony-stimulating  factor, 
erythropoietin,  and thrombopoietin.  A  limiting  dilution  analysis of long-term  culture-initiat- 
ing cells (LTC-IC) showed that the CD34+IL-6P, -  cells contained a larger number of LTC-IC 
than did the CD34+IL-6R + cells. In a serum-free suspension ofCD34+IL-61:( -  cells, the addi- 
tion of slL-6P, to the combination oflL-6 and SCF dramatically increased the total and multi- 
potential progenitors,  whereas CD34+IL-6R. + cells failed to do so under the same conditions. 
These  results  indicate  that  most  of the  erythroid,  megakaryocytic,  and  primitive  human  he- 
matopoietic progenitors  are included  in the  IL-61:(- populations,  and the  activation of gp130 
on  these progenitors  can be  achieved by a  complex  of IL-6-slL-6R,  but  not by IL-6 alone. 
The present culture system using IL-6, slL-6R., and SCF may provide a novel approach for ex 
vivo expansion of human primitive hematopoietic progenitors. 
I 
ntercellular communication in the hemopoietic system is 
mediated by soluble factors called IL or cytokines. These 
molecules  exert their biological  functions  through  specific 
receptors expressed on the surface of target cells. The clon- 
ing of genes  encoding  the  receptors  for cytokines regulat- 
ing the hematopoietic system has revealed that the majority 
of cytokine receptors falls into a hematopoietic cytokine re- 
ceptor superfamily.  Most cytokine  receptor systems in this 
family,  except for the  receptors  of erythropoietin  (EPO) 1, 
1Abbreviations used in this paper: BL, blast cell; BFU, burst-forming cells; 
CFU, colony-forming cells; CNTF, ciliary neurotrophic factor; E, eryth- 
roid; Eo, eosinophil; EPO,  erythropoietin; FBS, fetal bovine serum; G, 
granulocyte; G-CSF, granulocyte colony~stimulating factor; slL-6R., sol- 
uble IL-6R;  LIF, leukemia inhibitory  factor; LTC-IC, long-term  cul- 
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granulocyte  colony-stimulating factor (G-CSF),  and throm- 
bopoietin  (TPO), consist of a multichain complex, a ligand- 
specific  receptor chain  (et chain),  and  a  signal  transducing 
chain  ([3  chain),  the  latter  of which  is  often  common  to 
several receptor complexes (1-3).  The cytokines that share 
a  [3 chain  often mediate  similar functions  on various cells. 
In addition to functional redundancy,  each cytokine has its 
own unique  functions  in certain  cell types, suggesting that 
cellular  responsiveness  is largely  determined  by the  regu- 
lated expression of the ligand-specific receptors. 
ture-initiating cells; M, macrophage; Meg, megakaryocyte; Mix, mixed; 
NMC, nonphagocytic mononuclear cells; OSM, oncostatin M; SA-PE, 
PE-conjugated streptavidin; SCF, stem cell factor; TPO, thrombopoietin. 
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ally different  chains:  a  ligand-binding chain  (IL-6R.)  and 
signal-transducing gp130,  the latter of which  is shared by 
receptors of IL-11, leukemia inhibitory factor (LIF), onco- 
statin M  (OSM),  ciliary neurotrophic factor (CNTF),  and 
cardiotrophin  1  (3-5).  In the  IL-6R interaction, IL-6 first 
binds to the IL-6P,., and this complex (IL-6-slL-6R) then 
associates with gp130, leading to its homodimerization, and 
transduces  the  signal.  A  soluble form  of IL-6R  (slL-6R), 
lacking a transmembrane  and cytoplasmic region, has been 
shown to bind IL-6 with a binding affinity similar to that of 
the  entire  IL-6R molecule and  to  induce  homodimeriza- 
tion ofgpl30 upon IL-6 binding (1, 3, 6, 7). 
We recently demonstrated that a complex of IL-6-slL-6R, 
but  not  IL-6 alone,  can  activate gpl30  and  transduce  the 
functional signals to stimulate the ex vivo expansion of he- 
mopoietic  progenitors  from  human  CD34 +  cells  in  the 
presence  of stem  cell factor  (SCF)  (8).  We  have  also  ob- 
served  the  significant production  of erythroid  cells  from 
CD34 + cells in cuture with slL-61q, in the presence of IL-6 
and  SCF  and  lack  of this  production  in  culture  without 
sIL-6R (9). These results lead us to test the hypothesis that 
the  IL-6-sIL-6R complex  confers  IL-6  responsiveness  to 
primitive hemopoietic progenitors and  erythroid progeni- 
tors  that  show  no  expression  of  IL-6R  but  do  express 
gp130.  In this study, we examine the expression of gp130 
and IL-6P, on  CD34 +  ceils by flow cytometry, and dem- 
onstrate  that  gp130  is  ubiquitously  expressed  on  CD34 + 
ceils,  whereas  IL-6P,  displays  a  limited  expression.  Our 
comparison of the proliferation and differentiation capabili- 
ties  of FACS|  CD34+IL-6R +  cells with  those  of 
CD34+IL-6R -  cells using  methylcellulose clonal  culture, 
suspension culture, and a limiting dilution analysis of long- 
term culture-initiating cells (LTC-IC)  reveals that most of 
the erythroid, megakaryocytic, and prinfitive hematopoietic 
progenitors are included in  the  IL-6R-  populations.  The 
findings  obtained  in  this  study  provide  new  information 
concerning the  mechanism  that  controls the development 
of human  hematopoietic  stem/progenitor  cells  and  have 
potential clinical application. 
Materials and Methods 
Cell Preparation.  Human  umbilical cord blood samples,  col- 
lected according to  our  institutional guidelines, were  obtained 
during normal  full-term  deliveries. Human  bone  marrow  cells 
were aspirated from the posterior iliac crest of healthy adult vol- 
unteers  after  informed  consent  was  obtained.  Nonphagocytic 
mononuclear cells (NMC) were separated by Ficoll-Paque (Phar- 
macia LKB, Uppsala, Sweden) density gradient centrifugation af- 
ter depletion of phagocytes with silica (Immuno Biological Labo- 
ratories, Fujioka, Japan) (10). 
Receptor, Cytokines, and Antibodies.  rhlL-6  and  slL-6R  were 
prepared as described previously (11). rhSCF was kindly provided 
by Amgen Biologicals (Thousand Oaks, CA). rhTPO,  IL-3, and 
EPO  were generously provided by Kirin Brewery  (Tokyo, Ja- 
pan). G-CSF was kindly provided by Chugai Pharmaceutical Co. 
(Tokyo, Japan). All the cytokines were pure recombinant mole- 
cules and were used at concentrations that induced optimal re- 
sponse in methylcellulose culture of human  hematopoietic cells. 
These concentrations are 100 ng/nfl of SCF, 100 ng/ml of IL-6, 
200 U/ml of IL-3, 100  ng/ml ofG-CSF, 2 U/ml of EPO and 
4 ng/ml of TPO. 
The preparation of anti-human gp130 mAb (AM64) and anti- 
human  IL-6R mAb (MT18)  has been described previously (12, 
13).  The  anti-gp130  and  anti-IL-6R  mAbs  were  hiotinylated 
with N-hydroxysuccinimido-biotin (Pierce Chemical Co., Rock- 
ford, IL). FITC-conjugated mouse IgG1 mAb specific for CD34 
(8G12)  (CD34-FITC),  FITC- and biotin-conjugated irrelevant 
mouse  IgG1  mAbs,  and  PE-conjugated  streptavidin  (SA-PE) 
were provided by Becton Dickinson & Co.  (San Jose, CA). PE- 
conjugated goat anti-mouse IgG Ab and PE-cyanine 5-succini- 
midylester-conjugated SA  (SA-PE/Cy5)  were  purchased  from 
DAKO A/S (Glostrup, Denmark). 
Serum-free Suspension Culture.  The  sorted  ceils  were  incu- 
bated in serum-free suspension culture as we recently described 
(8) with a minor modification of a previously reported method 
(14). 1 ml of culture mixture containing 200 sorted cells, o~-mediunl 
(Flow  Laboratories, Rockville,  MD),  2%  deionized pure  BSA 
(Sigma  Chemical  Co.,  St.  Louis,  MO),  10  txg/ml  of insulin 
(Sigma Chemical Co.), 200  Ixg/ml of transferrm (Sigma Chenfi- 
cal Co.), 0.01  mM 2-ME (Eastman  Organic Chemicals, Roches- 
ter,  NY),  and  40  b~g/ml  of  low-density  lipoprotem  (Sigma 
Chemical Co.), and different combinations of cytokines were in- 
cubated in 24-well tissue plates (Nunc, Roskilde, Denmark) at 37~ 
in  a humidified atmosphere flushed with 5%  CO  2,  5%  O2,  and 
90% N 2. At weekly intervals, cultures were demidepopulated by 
the removal of half the culture volume, which was then replaced 
by newly prepared medium with the same combinations ofcyto- 
kines. Cells in the collected media were washed, counted, cyto- 
centrifuged, and stained. Total progenitor cells generated at each 
time point in the suspension culture were evaluated by culturing 
a fraction of  the expanded cells in the clonat assay as described below. 
Clonal Cuhure.  The  sorted cells  and  their progenies in sus- 
pension culture were incubated in triplicate at concentrations of 
200  cells/ml for the  sorted CD34+IL-6R -  and  CD34+IL-6R + 
cells and 0.4-10  ￿  103 cells/ml for cultured cells in methylcellu- 
lose culture as previously reported (15,  16).  1 ml of culture mix- 
ture containing cells, o~-medium,  0.9%  methylcellulose (Shinetsu 
Chemical, Tokyo, Japan), 30% fetal bovine serum (FBS; Hyclone 
Laboratories Inc., Logan, UT), 1% &ionized fraction V BSA (Sigma 
Chemical Co.), 0.05 mM 2-ME, and various combinations ofcy- 
tokines was plated in 35-ram Lux standard  nontissue  culture dishes 
(Nunc)  and  incubated  at  37~  in  a  humidified  atmosphere 
flushed with 5% CO2  in air. For megakaryocyte colony forma- 
tion,  the  culture contained components  identical to  those  in 
serum-containing culture with the exception of FBS replaced by 
human platelet-poor plasma.  Serum-free methylcellulose culture 
contained components identical to those in serum-containing cul- 
ture except that 1% pure BSA, 200 Izg/ml of human transferrin, 
160 txg/ml of  soybean lecithin (Sigma Chenfical Co.), and 96 Izg/nfl 
of cholesterol (Nacalai Tesque, Kyoto, Japan)  replaced the BSA 
and FBS (17).  A  combination of early and late acting cytokines 
including SCF, IL-6, IL-3, G-CSF, and EPO, was used to deter- 
mine the expanded progenitors generated in suspension culture at 
each time point. All cultures were scored at day 14 according to 
criteria reported previously (10,  15, 16). A combination of TPO, 
SCF, and 1L-3 was used for the determination ofmegakaryocytic 
progenitors in the plasma-containing culture, and the megakaryo- 
cyte colonies were scored at day 11. To assess the accuracy of the 
in situ identification of colonies, individual colonies were lifted 
with an Eppendorf micropipette under direct nficroscopic visual- 
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Shandon Southern Instruments Inc., Sewickley, PA), and stained 
for  morphological examination. Staining with  May-Grfinwald- 
Giemsa was performed.  Imnmnostaining with the alkaline phos- 
phatase antialkaline phosphatase method using mAbs against gly- 
coprotein  Ilb/Illa  complex  (Nichirei  Co.,  Tokyo, Japan)  was 
carried out as described previously (18).  The abbreviations used 
for the colony types are as follows: G, granulocyte colonies; M, mac- 
rophage colonies; GM, granulocyte-macrophage colonies; E, ery- 
throid bursts; Eo, eosinophil colonies; Meg, megakaryocyte colo- 
nies; Mix, mixed colonies; and BL, blast cell colonies. 
How Cytometty and Cell Sorting.  Cell staining with CD34, gp 130, 
and IL-6R markers was performed with NMC obtained from hu- 
man cord blood. 2  ￿  106 NMC were suspended in 200  I.tl PBS 
with 2.5% FBS. Incubation with antibodies was carried out on ice 
for 30  rain.  For two-dimensional flow-cytometric analysis with 
CD34  and IL-6R,  NMC  were  first  incubated with biotinylated 
anti-IL-6R mAb and then incubated simultaneously with CD34- 
FITC  and  SA-PE.  For  three-dimensional analysis with  CD34, 
IL-6R,  and gp130,  NMC  were  first  incubated with anti-IL-6R 
mAb without labeling and then reacted with PE goat anti-mouse 
IgG Ab. To block surplus second antibody, nomaal mouse serum 
was added and further incubated with NMC.  Finally, the NMC 
were  stained  with  biotinylated  anti-gp130  mAb  followed  by 
staining with SA-PE/Cy5 and CD34-FITC. Cells were analyzed 
on  a  FACScan  flow  cytometer  (Becton  Dickinson  &  Co.).  A 
morphologic  gate  including "o25%  of  the  events  and  all  the 
CD34 + cells  was determined on two-parameter histogram~ (side 
scatter  and  forward  scatter).  Compensation  for  two-color-  or 
three-color-labeled samples was  set up with single-stained sam- 
pies.  Positivi  W or negativity for IL-6R and gp130 antigens among 
CD34 + cells was determined using control cells that were stained 
with  the  FITC-,  PE-,  and  PE/Cy5-1abeled  irrelevant  mouse 
IgG1  mAb  as  their  isotype-matched  controls.  Cell  sorting was 
performed on a flow cytometer (EPICS Elite; Coulter Electronics 
inc.,  Hialeah,  FL).  The  purity  of sorted  CD34+IL-6R +  and 
CD34+lL-6R  -  populations as verified by reanalysis was  >95%. 
For clone sorting, the sorted cells were resorted singly into 96-well 
flat-bottomed plates (Nunc) with a FACStar Plus equipped with an 
automated  cell  deposition  unit  (ACDU;  Becton  Dickinson  & 
Co.). The clone-sorted cells were cultured in each well containing 
200  Ftl serum-containing methylcellulose culture  medium sup- 
plemented with SCF, IL-6, IL-3, G-CSF, and EPO. 
A  Limiting Dilution Analysis  of LTC-IC.  To  prepare  feeders, 
mononuclear cells obtained from the adult bone marrow donor were 
used as described (19-21).  The mononuclear cells were first  cul- 
tured at a concentration of 2  ￿  107 ceils per T25 flask in a-medium 
containing 20%  FBS  and  0.05  mM  2-ME.  After  culturing for 
2 wk,  >80% of the confluent stromal layers were irradiated (15 
Gy of 250-kV peak x rays) and trypsinized. The cells were resus- 
pended in LTC  medium (MyeloCult H5100;  Stem Cell Tech- 
nologies Inc., Vancouver,  Canada)  supplemented with  10  -6 M 
hydrocortisone  and  seeded  in  96-well flat-bottomed microwell 
plates  at  5  ￿  104  cells  per  well  for  reestablishing the  stromal 
feeder layer. The following day, the sorted cells were plated into 
each of the 96 wells at six different dilutions (range 12-400 cells/ 
well) with  a  total  volume of 200  ptl/well.  At weekly intervals, 
half of the nonadherent cells were removed, and at the same time 
half of the medium was  replaced.  After 5  wk,  the nonadherent 
cells  and the adherent cells  suspended by treatment with trypsin 
were washed and plated in clonal methylcellulose culture supple- 
mented with  SCF,  1L-6,  IL-3,  G-CSF,  and EPO  to  determine 
the total clonogenic cell content of each LTC. 
Results 
Expression  of  IL-6R  and  gpl30  on  Human  Cord  Blood 
CD34 + Cells.  To  examine the  expression  of IL-6P,.  and 
gp130 on human CD34 +  cells, cord blood NMC  were pre- 
pared for flow-cytometric  analysis. The  expression of CD34 
was first analyzed on NMC  within the low forward- and side- 
scatter properties. On a population of CD34 + cells determined 
based on the isotype-matched control, then, the expression 
of IL-6R and gp130  was  analyzed.  IL-6R was  identified on 
30-50%  of total CD34 +  cells, whereas  the remainder (50- 
70%) of the CD34 + cells were IL-6R-  (Fig.  1 A). In contrast, 
most of the CD34 + cells were shown to express gp130 low 
positively  (Fig.  1  /3).  When  the  expression  of IL-6R and 
gp130  on CD34 +  cells was  characterized  on three-dimen- 
sional flow cytometric analysis, most of the CD34 + cells were 
gp130  I~  whereas more than half of the CD34 + gp130  l~  cells 
did not express IL-6R (Fig. 1 C). These results clearly indicate 
that two populations ofgpl30  l~  IL6R + and gp1301~ 
cells were present in human cord blood CD34 +  cells. 
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Figure  1.  Flow cytometric  analysis of human cord  blood  CD34  + cells. (A) CD34-FITC and lL-6P,-biotin-SA-PE (IL-6 receptor-PE) profile; (/3) 
CD34-FITC and gp130-biotin-SA-Cy5 (gp130-PECy5) profile;  (C) IL-6R-PE and gp130-Cy5 profile on CD34  + cells. The CD34  + cells were de- 
termined on CD34-FITC histogram. Positivity or negativity for antigens was determined using their isotype-matched controls. 
1359  Tajima et al. Table  1.  Colony Formation  from CD34+ IL-6R + and CD34+ IL-6R -  Cells in Serum-free Methylcellulose Culture Supplemented 
with IL-6, slL-6R and SCF 
Number of colonies per 200 cells 
Cell type  Factors  G  M  GM  E  Mix  Meg  BL  Total 
CD34+IL-6R § 
CD34+IL-6R - 
SCF  0  0  0  0  0  0  5  +  3  5+3 
SCF-IL-6  0  2  +- 2  0  0  0  0  6  +  1  9 +  3 
SCF-IL-6-slL-6R  7  +-- 2  10  +  4  3  +~  1  1 ~  1  0  0  1 +~  1  22 +  5 
SCF  0  0  0  0  0  0  2  +  2  2+2 
SCF-IL-6  0  0  -2-- 1  0  0  0  0  3  +- 3  4 +  3 
SCF-IL-6--slL-6R  5  +  3  4  +  2  1 +  1  42  +  15  32  +  6  3  +- 2  3  +  2  90  -+  19 
Cells were cultured in the presence  of designated  factor combinations,  and colonies were scored at day 14. The number of colonies indicates mean 
+-- SD of triplicate  cultures. 
Effects  of slL-6R,  IL-6,  and  SCF on  Colony  Formation  of 
CD34+IL-6R + and  CD34+IL-6R -  Cells  in  Serum-free Me- 
thylcellulose  Culture.  The  data  shown  in  Fig.  1  indicating 
that  a  significant proportion  of CD34 +  cells express  gp130 
but not IL-6R suggested that those  cells may be responsive 
to  IL-6-slL-6R  but  not  IL-6  alone.  To  examine  whether 
CD34+IL-6R -  cells were  functionally  disfnct  from  CD34 + 
IL-6R +  cells  in  response  to  IL-6  or  slL-6R-IL-6,  a  cell 
sorting  of both  populations  was  performed,  and  the  200 
sorted  cells  were  cultured  in  serum-free  methylcellulose 
culture  containing  100  ng/ml of IL-6,  1  I~g/ml of slL-6R, 
and  100  ng/ml  of SCF  (Table  1).  SCF alone  or in combi- 
nation with  IL-6 induced  only a  small number  of colonies 
from both  CD34+IL-6R +  and  CD34+IL-6R -  cells, in ac- 
cordance  with  our previous  studies  (8).  An  increase  in the 
total  number  of colonies  was  observed  when  slL-6R  was 
added  to the culture  of both types of cells. The addition  of 
slL-6R  to  the  culture  of CD34+IL-6R +  cells induced  the 
increase  of the  number  of colonies,  most  of which  were 
GM  colonies. A  dramatic  effect of slL-6R was  observed in 
the culture ofCD34+IL-6R  -  cells. The addition ofslL-6R 
to  the  culture  of CD34+IL-6R -  cells  in  the  presence  of 
SCF  and  IL-6  increased  the  number  of colonies  by  22.5- 
fold with a  plating  efficiency of ~'-'50%.  Interestingly,  vari- 
ous types of colonies including E  bursts,  Meg, and Mix col- 
onies  in  addition  to  GM  colonies,  were  derived from  the 
CD34+IL-6R -  cells. 
Hemopoietic Colony-forming Capacity of CD34+ IL-6R + and 
CD34+IL-6R -  Cells.  These results suggest that the CD34 + 
cells may be classified into two distinct subgroups  of CD34 + 
IL-6R-  and  CD34+IL-6R +  cells with  different  functional 
capabilities.  To  test  this  hypothesis,  200  sorted  CD34 + 
IL-6R +  and  CD34+IL-6R -  cells were  cultured in serum- 
containing  methylcellulose  cultures  with  SCF,  IL-3,  IL-6, 
G-CSF,  and EPO,  Table 2  shows  the results  of two repre- 
sentative experiments.  In both experiments,  the cloning ef- 
ficiency  of CD34+IL-6R -  cells  was  higher  than  that  of 
CD34+IL-6R +  cells,  and  >90%  of the  colonies  formed 
from CD34+IL-6R + cells were GM  colonies, including Eo 
colonies, whereas CD34+IL-6 -  cells gave rise to various types 
of colonies including  not  only  G/M  and  Eo  colonies,  but 
also E  bursts and Mix colonies. We simultaneously carried out 
plasma-containing  methylcellulose  culture  supplemented 
with SCF,  IL-3, and  TPO  for the precise detection of Meg 
Table  2.  Colony Formation  Jrom CD34+ IL-6R + and CD34+ IL-6R  Cells in Clonal Culture 
Type of colonies 
Cloning 
Experiment  Cell type  efficiency  G  M  GM  Eo  E  Mix  BL 
% 
1  CD34+IL-6R +  39.5  29. l  57.8  10.5  1.7  0.0  0.8  0.0 
CD34+IL-6R -  60.2  28.3  13.6  2(}.5  2.5  19.9  13.6  1.7 
2  CD34+IL-6R +  56.5  28.6  48.7  17.1  3.5  0.9  0.(}  1.2 
CD34+IL-6R -  72.7  10.1  4.8  7.0  1.0  46.1  28.l  3.1 
200 cells were cultured in serum-containing methylcellulose culture with SCF, IL-6, 1L-3, G-CSF, and EPO, and colonies were scored on day 14. 
The cloning efficiency and the percentage of each type of colonies indicate  the mean of triplicate  cultures. 
1360  IL-6R and gp130 Expressions and Proliferation ofCD34 + Cells Table 3.  Colony Formation from Clone-sorted CD34+ IL-6  + 
and CD34+ IL-6R -  Cells 
Cell type 
Number of colonies 
Number of 
clone-sorted cells  G  M  GM  E  Mix  Total 
CD34+IL-6R  +  95  1  11  14  0  0  26 
CD34+IL-6R  -  96  2  2  4  12  26  46 
Clone-sorted  CD34+IL-6R  +  and  CD34+IL-6R  -  cells  by  FACStar  | 
PLUS equipped with ACDU were cultured in serum-containing meth- 
ylcellulose culture with SCF,  IL-6, IL-3, G-CSF, and EPO, and colo- 
nies were scored at day 14. 
colonies. Whereas  CD34+IL-6R  +  cells  produced no Meg 
colonies,  13  +  1  Meg colonies were  generated  from 200 
CD34+IL-6R  -  cells.  These results indicate that IL-6R ex- 
pression on CD34 +  cells  might be limited  to mainly GM 
colony-forming cells (CFU-GM), whereas CD34+IL-6R  - 
cells  contain  various  types  of  progenitors,  including  E 
burst-forming  cells  (BFU-E),  Meg  colony-forming  cells 
(CFU-Meg), and Mix colony-forming cells (CFU-Mix), in 
addition to CFU-GM. 
We further carried out the methylceUulose culture of sin- 
gle cells clone sorted by use of FACStar  |  PLUS ACDU in the 
presence  of SCF,  IL-3, IL-6, G-CSF,  and EPO  to deter- 
mine  the  colony-forming capacity of CD34+IL-6R  +  and 
CD34+IL-6R  -  cells more precisely. As shown in Table 3, 
most  colonies  derived  from  single  CD34+IL-6R  §  cells 
were  also  GM  colonies,whereas  the  CD34+IL-6R  -  cells 
generated various types of colonies such as E  bursts,  Meg, 
and  Mix  colonies  in  addition  to  GM  colonies.  When 
clone-sorted  cells  were  cultured  in  the  presence  of TPO, 
SCF, and IL-3, 96 CD34+IL-6R  + cells produced only one 
Meg  colony,  whereas  10  Meg  colonies  were  generated 
from 96  CD34+IL-6R  -  cells.  These  results  in the  culture 
of clone-sorted cells confirmed the  observations shown in 
Table 2. 
The  Frequency  of LTC-IC  in  CD34+IL-6R +/-  Popula- 
tions.  The result that CD34+IL-6R  -  cells produced a sig- 
nificantly larger number of Mix colonies suggests that more 
primitive progenitors may be contained in the CD34+IL-6R  - 
population  than  in  the  CD34+IL-6R  +  population.  We 
then assayed the frequency of LTC-IC, which are believed 
to reflect primitive hematopoietic  progenitor cells,  in each 
sorted population.  CD34+IL-6R  + and CD34+IL-6R  -  cells 
were distributed  into microwells containing preestablished 
irradiated  adherent layer cells.  For each evaluation,  six cell 
concentrations  were  used  with  12-24  replicates  per  con- 
centration. The frequency of negative wells (no clonogenic 
progenitors  detectable  5  wk  later)  was  then  determined. 
The frequency of LTC-IC in the  starting population  was 
calculated  by  Poisson  statistics  and  the  weighted  mean 
method with iterative procedures to determine the best lin- 
ear fit (22)  (Fig. 2). The frequency of LTC-IC in a popula- 
tion of CD34+IL-6R  + cells was 1:1,264, whereas that in a 
population  of CD34+IL-6R  -  cells  was  1:199,  indicating 
that  the  CD34+IL-6R  -  population  included more  primi- 
tive progenitor cells than the CD34+IL-6R  + population. 
Expansion  of Clonogenic  Progenitor  Cells in  Serum-free  Sus- 
pension  Cultures  of CD34+ IL-6R + and  CD34+ IL-6R -  Cells. 
Our  previous  study  demonstrated  that  the  expansion  of 
primitive  progenitor  cells  in  a  CD34  +  population  can be 
achieved  with  the  combined  signals  through  gp130  and 
c-Kit  initiated  by slL-6R,  IL-6,  and  SCF  (8).  Therefore, 
our current observation that most of the primitive progeni- 
tors belong to the population of CD34+IL-6R  -  cells suggests 
that  hematopoietic  progenitor  cells  in the  CD34§  - 
cells may be expanded more effectively by the stimulation 
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Figure 2.  Quantitation of LTC-IC by limiting dilution 
analysis. Six dilutions of CD34+IL-6R  + cells (circles)  and 
CD34+IL-6R  -  cells (squares)  were cultured  over irradi- 
ated  stromal layers,  and  the  number of clonogenic  cells 
detectable  after 5 wk was determined. In this experiment, 
the  frequency of LTC-IC  was  1:1,264  cells  in  CD34  + 
IL-6R  §  cells  (dotted  line)  and  1:199  cells  in  CD34+IL  - 
6R- cells (solid line). 18000- 
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Figure  3.  Generation  of total progenitors (A) and CFU-Mix  (B)  from 
3  X  l()  2 CD34+IL-6P,.  +  cells containing 167 progenitors and no  CFU- 
Mix, and 3  ￿  102 CD34+IL-6R. -  cells containing 218 progenitors and 56 
CFU-Mix  in suspension cultures supplemented with SCF and IL-6 in the 
presence  or absence ofslL-6R  at day 7  (open  bars),  day 14  (hatched  bars), 
and day 21  (solid  bars). The  data presented are from a  single experiment. 
Similar data were obtained in two additional experiments. 
of IL-6,  slL-6R,  and  SCF.  To  examine  this  possibility, 
sorted  CD34+IL-6R +  and  CD34+IL-6P,  -  cells  were  cul- 
tured in serum-free suspension culture supplemented with a 
combination ofslL-6R, IL-6, and SCF. The results showed 
that significant expansion ofhematopoietic progenitors from 
CD34+IL-6R  -  cells  but not CD34+IL-6R  +  cells  occurred 
(Fig.  3).  The  addition  of slL-6R  to  the  combination  of 
SCF and  IL-6 increased  the  generation  of progenitor  cells 
from CD34+IL-6R -  cells.  The increase of total and multi- 
potential progenitors was 11.1- and 7.4-fold at day 7, 25.3- 
and 27.1-fold at day 14,  and 540.6-  and  103.5-fold at day 
21  of suspension  culture,  respectively.  In  contrast,  in  the 
suspension  culture  of CD34+lL-6R + cells,  the addition  of 
slL-6R failed  to  stimulate  the  progenitor  expansion.  This 
result suggests that our previous observation  of the expan- 
sion of primitive progenitors from CD34 + cells  by slL-6R, 
IL-6, and SCF was mainly provided by the highly prolifer- 
ative  capability  of the  CD34+IL-6P,.  -  cell  subpopulation, 
and that the CD34+IL-6R.  -  cell population  can be a good 
target  cell  population  for  ex  vivo  expansion  using  IL-6, 
slL-6R, and SCF. 
Discussion 
The unparalleled expression pattern ofgpl30 and IL-6R. 
on  human  cord  blood  CD34 +  cells  was  demonstrated  by 
our flow-cytometric studies. Most of the CD34 + cells were 
found to express gp130 in accordance with previous reports 
that gp130 is ubiquitously expressed in all tissues  examined 
(7,  23,  24).  By contrast,  half to  two  thirds  of the  CD34 + 
cells  lacked  the  expression  of IL-6R.  The  CD34+IL-6P,  - 
cells  may  have  other  ligand-specific  receptor(s)  requiring 
gp130  as  a  signal  transducer.  In  our recent  studies,  IL-11 
and LIF were shown to have comparable effects with  IL-6 
on colony formation from cord blood CD34 +  cells  in the 
presence of SCF, and no stimulator,/effects  were observed 
with OSM and CNTF (25). These suggest that the expres- 
sion of receptors for IL-11 and LIF reveal a similar distribu- 
tion  to  that  of IL-6R  on  CD34 +  cells,  and  that  CD34 + 
cells  express  little  or  no  receptors  for  OSM  and  CNTF. 
However, there remains a possibility that unknown ligand- 
specific receptor(s) using gp130 may present on the CD34 + 
IL-6R- cells. 
The  characterization  of the  two  distinct  subpopulations 
of CD34 + cells was carried out using sorted  CD34+IL-6R + 
and  CD34+IL-6R  -  cells.  In serum-containing  clonal  cul- 
ture supplemented  with SCF, IL-3, IL-6, G-CSF, and EPO, 
or plasma-containing clond culture supplemented with TPO, 
SCF,  and  IL-3,  most  of the  colonies  generated  from the 
CD34+lL-6R +  cells  were  GM  colonies,  whereas  CD34 + 
IL-6R- cells  gave rise  to various types of colonies, includ- 
ing E  bursts,  Meg,  and  Mix  colonies,  in  addition  to  GM 
colonies.  Furthermore,  LTC-IC  assay  showed  that  the 
CD34+IL-6R  -  population  contained  a  larger  number  of 
LTC-IC  than  did  the  CD34+IL-6  +  population.  Similar 
data  were  obtained  from experiments  using bone  marrow 
CD34+IL-6R + and CD34+IL-6R -  cells  (data not shown). 
These  results  indicate  that  CD34+IL-6R +  progenitors  are 
already  committed  for  myeloid  lineage,  whereas  CD34 + 
IL-6R-  cells  contain  myeloid,  erythroid,  megakaryocytic, 
multipotential progenitors and more primitive hematopoietic 
progenitor cells.  This model  can  explain  our previous ob- 
servation that cord blood CD34 + cells formed various types 
of colonies,  including GM,  E  bursts,  Meg,  and Mix  colo- 
nies in serum-free  clonal culture  supplemented  with  I1.-6, 
sIL-6R, and SCF, whereas a combination of SCF and IL-6 
induced  only a  small  number  of GM  colonies  (8).  It  has 
been shown that IL-6 in combination with IL-3 or SCF in- 
duces  the  proliferation  of murine  5-fluorouracil-resistant 
multipotential hematopoietic progenitor cells,  suggesting the 
expression of IL-6R on murine prmfitive hematopoietic pro- 
genitor cells  (26).  Therein  may lie  the  difference between 
the  IL-6R  expression  pattern  on  murine  and  human  be- 
matopoietic cells. 
The essential role ofgpl30 in hematopoiesis in vivo was 
confirmed in gp130-deficient  mice  (27).  The  mutant  enl- 
bryos  had  greatly  reduced  numbers  of pluripotential  and 
committed hematopoietic progenitors such as spleen colony- 
forming cells  (CFU-S), CFU-GM, BFU-E, and CFU-Meg 
in  the  liver,  and  some  showed  severe  anemia  due  to  im- 
paired maturation oferythroid cells.  The in vivo role of c-Kit 
in hematopoiesis  has  been  well  documented in W-nmtant 
mice (28).  The mice revealed decreased numbers of CFU-S 
and erythroid progenitors.  In addition,  human serum  con- 
tains detectable levels ofSCF, IL-6, and sIL-6R, as well as a 
functional complex of IL-6--slL-6R (29-31).  Taken together 
with  the in vitro  data,  the  synergistic effects of gp130 and 
c-Kit signaling play a vital role in the proliferation and dit: 
ferentiation of hematopoietic progenitor cells  in vivo. 
There has been great interest in ex vivo expansion of hu- 
man  primitive  hematopoietic  progenitor  cells  for  clinical 
1362  IL-6R and gp130 Expressions and Proliferation ofCD34  + Cells application, including gene  therapy.  So  far,  however,  the 
ex vivo expansion methods reported previously may be in- 
sufficient because primitive hematopoietic progenitors dif- 
ferentiated  to  mature  otigopotent  progenitors  during  ex- 
pansion.  In  this  study,  significant  expansion  of not  only 
total progenitors but also multipotential hematopoietic pro- 
genitors was  obtained from  sorted  CD34+IL-6R -  cells in 
serum-free  suspension  culture  supplemented  with  IL-6, 
slL-6R,  and  SCF.  Because  it  is  conceivable  that  human 
primitive hematopoietic progenitor cells express both gp130 
and c-Kit, coactivation of the gp130 and c-Kit signal path- 
way by the three factors may provide a novel approach for 
expansion of human primitive hematopoietic progenitor cells. 
We thank Ms. Ikuko Tanaka for technical support. 
This work was supported by grant from the Ministry of Education, Science, Sports and Culture, Japan. 
Address correspondence to Tatsutoshi Nakahata, Department of Clinical Oncology, The Institute of Medi- 
cal Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan. 
Received  for publication  30 May  1996 and in revised  form 2July  1996. 
References 
1.  Kishimoto, T., T. Taga, and S. Akira. 1994.  Cytokine signal 
transduction. Cell. 76:253-262. 
2.  Ogawa,  M.  1993.  Differentiation  and  proliferation  of he- 
matopoietic stem cells. Blood. 81:2844-2853. 
3.  Taga,  T.,  and  T.  Kishimoto.  1995.  Signaling  mechanism 
through cytokine receptors that share signal  transducing re- 
ceptor components. Curr. Opin.  Immunol.  7:17-23. 
4.  Hibi, M., M.  Murakami, M.  Sato, T.  Hirano, T.  Taga, and 
T. Kishimoto. 1990.  Molecular cloning and expression of an 
IL-6 signal transducer, gp130. Ceil. 63:1149-1157. 
5.  Saito, M., K. Yoshida, M. Hibi, T. Taga, and T. Kishimoto. 
1992.  Molecular cloning of a murine IL-6 receptor-associated 
signal transducer, gp130, and its regulated expression in vivo. 
J. Immunol.  148:4066-4071. 
6.  Murakami,  M.,  M.  Hibi,  N.  Nakagawa,  K.  Yasukawa,  K. 
Yamanishi, T.  Taga, and T.  Kishimoto. 1993.  IL-6-induced 
homodimerization of gp 130 and associated activation of a ty- 
rosine kinase. Science (Wash.  DC). 260:1808-1810. 
7.  Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. 
Matsuda, T. Hirano, and T.  Kishimoto.  1989.  Interleukin-6 
triggers the association of its receptor with a possible signal 
transducer, gp130. Cell. 58:573-581. 
8.  Sui, X., K. Tsuji, R.. Tanaka, S. Tajima, K. Muraoka, Y. Ebi- 
hara, K. Ikebuchi, K. Yasukawa, T. Taga, T. Kishimoto, and 
T. Nakahata.  1995.  gp130 and c-Kit signalings synergize for 
ex vivo expansion of human primitive hemopoietic progenitor 
cells. Proc. Natl.  Acad. Sci. USA.  92:2859-2863. 
9.  Sui, X., K. Tsuji, S. Tajima, R. Tanaka, K. Muraoka, Y. Ebi- 
hara, K. Ikebuchi, K. Yasukawa, T. Taga, T. Kishimoto, and 
T.  Nakahata.  1996.  Erythropoietin-independent erythrocyte 
production:  signals  through  gp130  and  c-Kit  dramatically 
promote  erythropoiesis from  human  CD34 §  cells. J.  Exp. 
Meal. 183:837-845. 
10.  Imai,  T.,  K.  Koike, T.  Kubo,  T.  Kikuchi,  Y.  Amano,  M. 
Takagi, N.  Okumura, and T. Nakahata.  1991.  Interleukin-6 
supports human megakaryocytic proliferation and differentia- 
tion in vitro. Blood. 78:1969-1974. 
11. Yasukawa, K., T. Saito, T. Fukunaga, T. Sekimori, Y. Koish- 
ihara,  Y.  Fukui,  H.  Ohsugi,  Y.  Matsuda,  T.  Yawata,  H. 
Hirano et al.  1990.  Proliferation and characterization of solu- 
ble human IL-6 receptor expressed in CHO cells.J. Biochem. 
108:673-676. 
1363  Tajima et al. 
12. Taga, T., M. Narazaki, K. Yasukawa, T.  Saito, D. Miki, M. 
Hamaguchi, S. Davis, M. Shoyab, G.D. Yancopoulos, and T. 
Kishimoto. 1992.  Functional inhibition ofhematopoietic and 
neurotrophic cytokines by blocking the interleukin-6 signal 
transducer  gpl30.  Proc.  Natl.  Acacl. Sci. USA.  89:10998- 
11001. 
13. Saito,  T.,  T.  Taga,  D.  Miki,  K.  Futatsugi, H.  Yawata,  T. 
Kishimoto, and  K.  Yasukawa.  1993.  Preparation of mono- 
clonal antibodies against the  IL-6  signal transducer,  gpl30, 
that can  inhibit IL-6-mediated functions. J.  Immunol.  Meth- 
ods. 163:217-223. 
14. Mayani, H.,  and P.M.  Lansdrop.  1994.  Thy-1  expression is 
linked  to  functional  properties  of primitive hematopoietic 
progenitor cells from human umbilical cord blood. Blood. 83: 
2410-2417. 
15. Nakahata,  T.,  and  M.  Ogawa.  1982.  Hemopoietic colony- 
forming cells in umbilical cord blood with extensive capabil- 
ity to generate mono- and multipotential hemopoietic pro- 
genitors.J. Clin.  Invest. 70:1324-1328. 
16. Nakahata, T., S.S. Spicer, and M. Ogawa.  1982.  Clonal ori- 
gin of human erythro-eosinophilic colonies in culture. Blood. 
59:857-864. 
17. Koike, K., T. Nakahata, M. Takagi, T. Kobayashi, A. Ishiguro, 
K.  Tsuji,  K.  Naganuma,  A.  Okano,  Y.  Akiyama,  and  T. 
Akabane. 1988.  Synergism ofBSF-2/interleukin 6 and inter- 
leukin 3 on development of multipotential hemopoietic pro- 
genitors in serum-free culture.J. Exp. Med.  168:879-890. 
18. Okumura, N., K. Tsuji, and T. Nakahata.  1992.  Changes in 
cell surface antigen expression during proliferation and differ- 
entiation of human erythroid progenitors. Blood. 80:642-650. 
19.  Sutherland, H.J., C.J. Eaves, A.C. Eaves, W. Dragowska, and 
P.M.  Lansdorp.  1989.  Characterization and partial purifica- 
tion of human  marrow cells capable of initiating long-term 
hematopoiesis in vitro. Blood. 74:1563-1570. 
20.  Sutherland,  H.J.,  P.M.  Lansdorp,  D.H.  Henkelman,  A.C. 
Eaves,  and  C.J.  Eaves.  1990.  Functional characterization of 
individual human hematopoietic stem cells cultured at limit- 
ing dilution on supportive marrow stromal layers.  Proc. Natl. 
Acad. Sci. USA.  87:3584-3588. 
21. Eaves,  C.J.,J.D. Cashman, and A.C. Eaves.  1991.  Methodol- 
ogy of long-term culture of human hemopoietic cells. J.  Tiss. 
Cult.  Methods.  13:55-62. 22.  Taswell, C.  1981.  Limiting dilution assays for the determina- 
tion of immunocompetent cell frequencies. J.  Immunol.  126: 
1614-1619. 
23.  Mackiewicz, A., H. Schooltink, P.C. Heinrich, and S. Rose- 
John.  1992.  Complex of soluble human IL-6-receptor/IL-6 
up-regulates expression of acute-phase proteins. J.  Immunol. 
149:2021-2027. 
24. Yoshida, K., I. Chambers, J. Nichols, A. Smith, M. Saito, K. 
Yasukawa,  M.  Shoyab,  T.  Taga,  and  T.  Kishimoto.  1994. 
Maintenance  of the  pluripotential phenotype of embryonic 
stem cells through direct activation of gp130 signaling path- 
ways. Mech.  Dev. 45:163-171. 
25.  Nakahata, T., X. Sui, R. Tanaka, S. Tajima, K. Muraoka, Y. 
Ebihara, and K. Tsuji. 1996.  Role ofgpl30 and c-Kit signal- 
ings in the proliferation and differentiation of human progen- 
itor cells. Cancer Chemother.  Pharmacol. In press. 
26. Tsuji, K., S.D. Lyman, T. Sudo, S.C. Clark, and M. Ogawa. 
1992.  Enhancement  of murine  hematopoiesis by synergistic 
interactions between  steel factor (ligand for c-kit), interleu- 
kin-11,  and  other early acting factors in culture.  Blood. 79: 
2855-2866. 
27. Yoshida  K.,  T.  Taga,  M.  Saito,  S.  Suematsu,  A.  Kuman- 
ogoh, T. Tanaka, H.  Fujiwara, M. Hirata, T. Yamagami, T. 
Nakahata et al.  1996.  Targeted disruption of gp130, a com- 
mon signal  transducer for IL-6 family of cytokines, leads to 
myocardial and hematological disorders. Proc. Natl. Acad.  Sci. 
USA. 93:407-411. 
28. Russell, E.S.  1979.  Hereditary anemias of the mouse:  a re- 
view for genetics. Adv.  Genet.  20:357-459. 
29.  Honda, M., S. Yamamoto, K. Cheng, K. Yasukawa, H. Su- 
zuki,  T.  Saito, Y.  Osugi,  T.  Tokunaga,  and T.  Kishimoto. 
1992.  Human  soluble IL-6  receptor,  its  detection and  en- 
hanced release by HIV infection.J. Immunol.  148:2175-2180. 
30. Lanley, K.E.,  L.G. Bennett, J.  Wypych, S.A. Yancik, X.D. 
Liu,  K.R.  Wastcott,  W.D.  Chang,  K.A.  Smith,  and  K.M. 
Zsebo. 1993.  Soluble stem cell factor in human serum. Blood. 
81:656-660. 
31.  Montero-Julian, F.A., J. Liautard, S. Flavetta, F. Romangne, 
J.P. Gaillard, J. Brochier, B. Klein, and H. Brailly. 1994.  Im- 
munoassay for functional human soluble interleukin-6 recep- 
tor in plasma based on ligand/receptor interactions. J.  Immu- 
nol. Methods.  169:111-121. 
1364  IL-6R and gpl30 Expressions and Proliferation ofCD34 + Cells 